Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
“My point is that the fda has 30 days but do they have to take all 30 days?” “I doubt it.”
“ Did you leave out a link because the quote is from a 2014 cancer trial? ” No because safety is safety!
“ Thirty-four percent of patients had an AS1411-related adverse event, all of which were mild or moderate” maybe they were concerned about the safety profile.
I like it!
“ Uncle Sam will not contribute....” Can you provide the PR that states this. Thanks!
They don’t need it. Just 2 people discussing public information.
SHAZAM!!
The only problem is that tamiflu really doesn’t work but other than that it’s all good!
Large institutional investors can’t even invest in otc stocks. B si 426!
A small quick 120 person trial? Yes!
What exactly is this chart showing? Thanks
SI of 426 for covid 19 is amazing! Go B!
I like that insiderfinancial article. I would love to see some momo players here tomorrow.
B at 426 is amazing!
I would rather wait a couple of weeks for real volume instead of the usual flipper gang run up.
Thanks I am not sure why anyone would argue about soc
Placebo will be soc
No idea what you just said but there are more soc options then remdesivir.
I am sure you are right about placebo being soc. No way would it be a “sugar pill”
Yesterday we had a bunch of new pumpers on board. I would bet we get a run today.
It seems like the study will be filled in 1 week and completed in 4 weeks? Does that seems about right.
Got the zip code trades going
Highlights
• Brilacidin potently inhibits SARS-CoV-2 in an ACE2 positive human lung cell line.
• Brilacidin achieved a high Selectivity Index of 426 (CC50=241µM/IC50=0.565µM).
• Brilacidin’s main mechanism appears to disrupt viral integrity and impact viral entry.
• Brilacidin and remdesivir exhibit excellent synergistic activity against SARS-CoV-2.
Significance Statement
SARS-CoV-2, the emergent novel coronavirus, has led to the current global COVID-19 pandemic, characterized by extreme contagiousness and high mortality rates. There is an urgent need for effective therapeutic strategies to safely and effectively treat SARS-CoV-2 infection. We demonstrate that brilacidin, a synthetic small molecule with peptide-like properties, is capable of exerting potent in vitro antiviral activity against SARS-CoV-2, both as a standalone treatment and in combination with remdesivir, which is currently the only FDA-approved drug for the treatment of COVID-19.”
The timing won’t matter. B will be done with the phase 2 for Covid by the time the peer review process is completed!
“ Highlights
• Brilacidin potently inhibits SARS-CoV-2 in an ACE2 positive human lung cell line.
• Brilacidin achieved a high Selectivity Index of 426 (CC50=241µM/IC50=0.565µM).
• Brilacidin’s main mechanism appears to disrupt viral integrity and impact viral entry.
• Brilacidin and remdesivir exhibit excellent synergistic activity against SARS-CoV-2.
Significance Statement
SARS-CoV-2, the emergent novel coronavirus, has led to the current global COVID-19 pandemic, characterized by extreme contagiousness and high mortality rates. There is an urgent need for effective therapeutic strategies to safely and effectively treat SARS-CoV-2 infection. We demonstrate that brilacidin, a synthetic small molecule with peptide-like properties, is capable of exerting potent in vitro antiviral activity against SARS-CoV-2, both as a standalone treatment and in combination with remdesivir, which is currently the only FDA-approved drug for the treatment of COVID-19.”
What we have is
1. Third party validation which will enable the whole process to move forward much faster.
2. Yes the scientific community and the government are f@cking slow... thanks for pointing that out! Lol
3. Money will follow opportunity. Now that we have our science validated and a new scientific advisor Investors will be much more interested.
Ipix is moving B forward fast. We had huge 3rd party validation this week! This will open many opportunities for ipix and it’s shareholders. Don’t listen to those that want to move the goal post! One day it was B failed no results now it’s the fda news is not going to happen.
Here we go: 1. It’s not enough 2. Old information 3. To late ... rinse and repeat!
We have just about heard all the usuals:
But you can bet we will hear a lot of .....
1. It’s not enough(fill in the blank)....
2. It’s taken to long
3. I don’t understand it... why didn’t they provide all of the info on( fill in blank)...
Wouldn’t B have a lot of potential applications as a inhaler?
I doubt he is just some guy who makes charts and videos. Lol! He and his followers see the opportunity with some news and then run up the stock he makes a chart and video. Rinse and repeat.
That’s my point! He and his followers weren’t here today! If they were it would of gone up on larger volume. He and his followers are usually like clock work when there is a pr like we had today.
Who is she
Another failure! Go B!
“ In the latest blow to the hoped-for class of therapeutics, Regeneron, the maker of the antibody therapy that President Trump credited (along with dexamethasone, a steroid) for his swift recovery has stopped enrollment in its trial for seriously ill patients after an independent authority wared of a safety issue.
”
What I find interesting is that there is no obvious sign of the usual clay trader gang this am. Why... are they expecting more news so they would lose control of their usual pump and dump? I don’t know but it’s interesting
“6 weeks late” clearly you are not familiar with the medical industry. Lol! Their always late!
But you can bet we will hear a lot of .....
1. It’s not enough(fill in the blank)....
2. It’s taken to long
3. I don’t understand it... why didn’t they provide all of the info on( fill in blank)...
LOL! Do you believe an anonymous email on an anonymous message board? Is that a joke?